Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Likelihood models for clustered binary and continuous outcomes: application to developmental toxicology.

M M Regan1, P J Catalano

  • 1Biometrics Center E/GZ-800, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA. meredith_regan@caregroup.harvard.edu

Biometrics
|April 21, 2001
PubMed
Summary

This study introduces a new statistical model for developmental toxicology. It jointly analyzes fetal malformations and low birth weight, improving dose-response modeling for risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer.

ESMO open·2026
Same author

Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR-positive/HER2-positive early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Corrigendum to "Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023": [Annals of Oncology 34 (2023) 970-986].

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Area of Science:

  • Developmental Toxicology
  • Quantitative Risk Assessment
  • Statistical Modeling

Background:

  • Current developmental toxicology methods often model dose-response relationships for fetal malformations and low birth weight separately.
  • Accounting for litter clustering is standard, but correlations between outcomes within a fetus are often overlooked.
  • Joint modeling may provide a more accurate representation of toxicological effects.

Purpose of the Study:

  • To propose a novel statistical model for jointly analyzing multiple developmental toxicity outcomes.
  • To extend existing correlated probit models to incorporate continuous outcomes like fetal weight.
  • To enable direct estimation of the joint risk of malformation and low birth weight.

Main Methods:

  • Development of a likelihood-based statistical model.

Related Experiment Videos

  • Extension of the correlated probit model to include continuous outcomes.
  • Incorporation of correlations between outcomes within a fetus and litter clustering.

    • Main Results:

    • The proposed model allows for different dose-response relationships for various outcomes.
    • It accounts for both within-fetus outcome correlations and litter-based clustering.
    • Marginal dose-response interpretations for individual outcomes are maintained.

    Conclusions:

    • The joint modeling approach offers a more appropriate framework for developmental toxicology studies.
    • This method enhances the estimation of joint risks, crucial for quantitative risk assessment.
    • The model is well-suited for determining safe dose levels in risk assessments.